PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
29-Jan-2021 Panthera continues to sign up new clinical trials across its UK network of dedicated clinical trial sites Panthera
29-Jan-2021 Epilepsy Therapeutic Market Therapeutic Development and Comprehensive Insights by 2026 Ameliorate Digital Consultancy PVT. LTD.
28-Jan-2021 Cancer Diagnostics Market Reviews and and Survey Report Forecast to 2025 (Based on COVID-19 North America Spread in 2020) Ameliorate Digital Consultancy PVT. LTD.
26-Jan-2021 Synairgen announces inclusion of its inhaled interferon beta treatment in US NIH ACTIV-2 trial in COVID-19 outpatients Synairgen
26-Jan-2021 First Patient Treated in Phase II Combination Trial of ISA Pharmaceuticals’ Lead Immunotherapy ISA101b with Keytruda® ISA Pharmaceuticals B.V.
26-Jan-2021 Panthera continues to sign up new clinical trials across its UK network of dedicated clinical trial sites Panthera
22-Jan-2021 PharmiWeb.Jobs Welcomes PRA Australia PRA Australia
22-Jan-2021 PharmiWeb.Jobs Welcomes Bausch & Lomb Bausch Health Companies Inc.
22-Jan-2021 Six key Microbiology presentations from FDA, STERIS, Boehringer Ingelheim Microbiological Consulting, Parexel SMi Group
21-Jan-2021 Sprint #4 Workshop: Bridging the silos between Clinical Research, eHealth & Digital Therapeutics - “The rise of patient-centric applications” Innovation Sprint
21-Jan-2021 Calliditas Announces Full Enrollment of the Phase 3 NefIgArd Trial Calliditas Therapeutics AB
21-Jan-2021 First Head & Neck Cancer Patient Treated in France in a Phase I trial with TG4050 (myvac® Platform), Transgene’s Innovative Individualized Immunotherapy Transgene
21-Jan-2021 CluePoints’ Risk-Based Quality Management Platform Instrumental in Data Quality Oversight of COVID-19 Trials CluePoints
21-Jan-2021 Prime Global and Raremark form strategic partnership to transform solutions and outcomes for patients with rare diseases Raremark
19-Jan-2021 Positive Phase 1 results in high-dose setanaxib trial Calliditas Therapeutics AB
19-Jan-2021 Awakn Life Sciences selects PRA Health Sciences as CRO for Phase II study of MDMA as a treatment for alcohol use disorder Awakn Life Sciences
19-Jan-2021 Quanticate appoints new Chief Operating Officer Quanticate
18-Jan-2021 Global healthtech company Raremark appoints Nicki Grundy as its Chief Financial Officer Raremark
17-Jan-2021 Registration Opens for SMi’s 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference (HPAPi) SMi Group
14-Jan-2021 Registration Opens for SMi’s 21st Annual Pain Therapeutics Virtual Conference SMi Group